#United States #New Haven #Valisure #Picket Pharmaceuticals #drug certification

Valisure and Picket Pharmaceuticals Team Up for Injectable Drug Assurance

In an innovative step towards improving the transparency and quality of pharmaceutical products, Valisure, known for its forward-thinking approach to healthcare supply chains, has partnered with Picket Pharmaceuticals. This collaboration aims to integrate Valisure's independent chemical analysis and certification program into the injectable drug offerings provided by Picket Pharmaceuticals.

The Urgency of Drug Quality and Availability

The U.S. pharmaceutical landscape has been increasingly plagued by a significant shortage of medications, particularly generic drugs. A combination of escalating market pressures and a troubling lack of transparency around drug quality has resulted in what many are calling a public health crisis. Between 2015 and 2020, a staggering 76% of documented drug shortages were linked to quality issues from manufacturers. In fact, recent records indicate that the alarming rate of drug recalls in the U.S. often stems from the presence of harmful impurities.

This new partnership between Valisure and Picket Pharmaceuticals is a timely response to these growing concerns, delivering independent testing and certification that can lead to safer, more effective medications for patients around the country. "Independent testing and quality transparency in the supply chain are vital to helping ensure the safety and efficacy of medications," stated David Light, Co-Founder and President of Valisure.

Uniting for Quality Assurance

The two companies found common ground through their collaboration in the End Drug Shortages Alliance (EDSA), where shared insights into the root causes of drug shortages paved the way for substantive changes in the pharmaceutical supply chain. Valisure and Picket Pharmaceuticals are devoted to establishing a model that enhances oversight and accountability, particularly at a time when drug accessibility has never been more crucial.

Picket Pharmaceuticals’ Founder and CEO, Joshua Kriger, echoed this sentiment, pointing out, "We’ve admired Valisure’s success in independent quality assurance in solid oral medications and recognized the urgent need for this capability within injectable drugs, an area already facing severe supply issues." This strategic alignment will enhance the existing quality manufacturing framework of Picket Pharmaceuticals, ensuring their products meet stringent safety and quality standards.

Commitment to Future Solutions

Valisure’s certification program will instill vital trust in Picket Pharmaceuticals' offerings by giving customers a clear view of the chemical quality of injectable drugs. This move aligns both companies with the need to advocate for systemic changes in the pharmaceutical sector, prioritizing quality in the sourcing and distribution of medications.

As the healthcare industry faces unparalleled challenges, this partnership signifies a proactive stance against further drug shortages while reinforcing the importance of reliability and safety in pharmaceuticals.

About Valisure and Picket Pharmaceuticals

Valisure operates at the forefront of transforming the healthcare supply chain by introducing independent certification processes vital for identifying quality. Their mission currently encompasses addressing real-time issues facing the drug market with heightened transparency. Picket Pharmaceuticals, on the other hand, is dedicated to alleviating the ongoing concern of drug shortages in the U.S. through robust manufacturing practices mixed with a strategic collaboration among stakeholders.

Together, Valisure and Picket Pharmaceuticals aim to usher in a new era of pharmaceutical reliability, pushing for transparency that both healthcare providers and patients can trust. As they continue their work, the prospect of a safer, more dependable medication supply chain lies ahead.